Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.

Hector, Emma; Cairns, Donald; Michael Wall, G

Hector, Emma; Cairns, Donald; Michael Wall, G.

Affiliation

Hector E; Robert Gordon University, Aberdeen, UK.
Cairns D; Robert Gordon University, Aberdeen, UK.
Michael Wall G; Nacuity Pharmaceuticals, Inc., Fort Worth, TX, USA. michael@nacuity.com.

Orphanet J Rare Dis ; 17(1): 231, 2022 06 16.

Article in En | MEDLINE | ID: mdl-35710564

Subject(s)

Cystinosis; Cell Culture Techniques; Cysteamine/pharmacology; Cysteamine/therapeutic use; Cysteine/metabolism; Cysteine/therapeutic use; Cystine/metabolism; Cystine/therapeutic use; Cystinosis/drug therapy; Cystinosis/genetics; Cystinosis/metabolism; Fibroblasts/metabolism; Humans

Key words

Cysteine; Cystine; Cystinosis; Human fibroblast; In vitro; N-acetylcysteine amide; NACA; diNACA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystinosis Limits: Humans Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google